Down-regulating humoral immune responses: Implications for organ transplantation

Mark D Stegall, Natalie Moore, Timucin Taner, Han Li, Patrick G. Dean

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Alloantibody can be a major barrier to successful organ transplantation; however, therapy to control antibody production or to alter its impact on the allograft remains limited. The goal of this review is to examine the regulatory steps that are involved in the generation of alloreactive B cells, with a specific emphasis on how known mechanisms relate to clinical situations in transplant recipients. Thus, we will examine the process of activation of mature, naïve B cells and how this relates to de novo antibody production. The role of long-lived plasma cells in persistent antibody production and the factors regulating their longevity will be explored. The regulation of memory B cells and their possible roles in alloimmunity also will be assessed. Finally, we will review current therapeutic approaches aimed at controlling alloantibody and assess their efficacy. By examining the pathways to antibody production mechanistically, we hope to identify important gaps in our current knowledge and gain insight into possible new therapeutic approaches to overcoming antibody in transplant patients.

Original languageEnglish (US)
Pages (from-to)247-257
Number of pages11
JournalTransplantation
Volume97
Issue number3
DOIs
StatePublished - Feb 15 2014

Fingerprint

Organ Transplantation
Humoral Immunity
Antibody Formation
Isoantibodies
B-Lymphocytes
Plasma Cells
Allografts
Therapeutics
Transplants
Antibodies

Keywords

  • Alloantibody
  • Antibody-mediated rejection
  • Complement
  • Humoral immunity
  • Immunoregulation
  • Kidney transplantation
  • Memory B cells
  • Plasma cells
  • Tolerance

ASJC Scopus subject areas

  • Transplantation

Cite this

Down-regulating humoral immune responses : Implications for organ transplantation. / Stegall, Mark D; Moore, Natalie; Taner, Timucin; Li, Han; Dean, Patrick G.

In: Transplantation, Vol. 97, No. 3, 15.02.2014, p. 247-257.

Research output: Contribution to journalArticle

Stegall, Mark D ; Moore, Natalie ; Taner, Timucin ; Li, Han ; Dean, Patrick G. / Down-regulating humoral immune responses : Implications for organ transplantation. In: Transplantation. 2014 ; Vol. 97, No. 3. pp. 247-257.
@article{60ca4a82a7ef47829d3c25bf7d4929ef,
title = "Down-regulating humoral immune responses: Implications for organ transplantation",
abstract = "Alloantibody can be a major barrier to successful organ transplantation; however, therapy to control antibody production or to alter its impact on the allograft remains limited. The goal of this review is to examine the regulatory steps that are involved in the generation of alloreactive B cells, with a specific emphasis on how known mechanisms relate to clinical situations in transplant recipients. Thus, we will examine the process of activation of mature, na{\"i}ve B cells and how this relates to de novo antibody production. The role of long-lived plasma cells in persistent antibody production and the factors regulating their longevity will be explored. The regulation of memory B cells and their possible roles in alloimmunity also will be assessed. Finally, we will review current therapeutic approaches aimed at controlling alloantibody and assess their efficacy. By examining the pathways to antibody production mechanistically, we hope to identify important gaps in our current knowledge and gain insight into possible new therapeutic approaches to overcoming antibody in transplant patients.",
keywords = "Alloantibody, Antibody-mediated rejection, Complement, Humoral immunity, Immunoregulation, Kidney transplantation, Memory B cells, Plasma cells, Tolerance",
author = "Stegall, {Mark D} and Natalie Moore and Timucin Taner and Han Li and Dean, {Patrick G.}",
year = "2014",
month = "2",
day = "15",
doi = "10.1097/TP.0b013e3182a72115",
language = "English (US)",
volume = "97",
pages = "247--257",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Down-regulating humoral immune responses

T2 - Implications for organ transplantation

AU - Stegall, Mark D

AU - Moore, Natalie

AU - Taner, Timucin

AU - Li, Han

AU - Dean, Patrick G.

PY - 2014/2/15

Y1 - 2014/2/15

N2 - Alloantibody can be a major barrier to successful organ transplantation; however, therapy to control antibody production or to alter its impact on the allograft remains limited. The goal of this review is to examine the regulatory steps that are involved in the generation of alloreactive B cells, with a specific emphasis on how known mechanisms relate to clinical situations in transplant recipients. Thus, we will examine the process of activation of mature, naïve B cells and how this relates to de novo antibody production. The role of long-lived plasma cells in persistent antibody production and the factors regulating their longevity will be explored. The regulation of memory B cells and their possible roles in alloimmunity also will be assessed. Finally, we will review current therapeutic approaches aimed at controlling alloantibody and assess their efficacy. By examining the pathways to antibody production mechanistically, we hope to identify important gaps in our current knowledge and gain insight into possible new therapeutic approaches to overcoming antibody in transplant patients.

AB - Alloantibody can be a major barrier to successful organ transplantation; however, therapy to control antibody production or to alter its impact on the allograft remains limited. The goal of this review is to examine the regulatory steps that are involved in the generation of alloreactive B cells, with a specific emphasis on how known mechanisms relate to clinical situations in transplant recipients. Thus, we will examine the process of activation of mature, naïve B cells and how this relates to de novo antibody production. The role of long-lived plasma cells in persistent antibody production and the factors regulating their longevity will be explored. The regulation of memory B cells and their possible roles in alloimmunity also will be assessed. Finally, we will review current therapeutic approaches aimed at controlling alloantibody and assess their efficacy. By examining the pathways to antibody production mechanistically, we hope to identify important gaps in our current knowledge and gain insight into possible new therapeutic approaches to overcoming antibody in transplant patients.

KW - Alloantibody

KW - Antibody-mediated rejection

KW - Complement

KW - Humoral immunity

KW - Immunoregulation

KW - Kidney transplantation

KW - Memory B cells

KW - Plasma cells

KW - Tolerance

UR - http://www.scopus.com/inward/record.url?scp=84894025549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894025549&partnerID=8YFLogxK

U2 - 10.1097/TP.0b013e3182a72115

DO - 10.1097/TP.0b013e3182a72115

M3 - Article

C2 - 24056631

AN - SCOPUS:84894025549

VL - 97

SP - 247

EP - 257

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 3

ER -